Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

NCT01196390 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

203

Enrollment

NIH

Sponsor class

Conditions

Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Stage IB Esophageal Cancer AJCC v7
Stage IIA Esophageal Cancer AJCC v7
Stage IIB Esophageal Cancer AJCC v7
Stage IIIA Esophageal Cancer AJCC v7
Stage IIIB Esophageal Cancer AJCC v7

Interventions

DRUG: Carboplatin
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
OTHER: Quality-of-Life Assessment
RADIATION: Radiation Therapy
PROCEDURE: Therapeutic Conventional Surgery
BIOLOGICAL: Trastuzumab

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]